| 注册
首页|期刊导航|河北医学|呲柔比星膀胱内灌注在膀胱癌术后治疗中的效果观察

呲柔比星膀胱内灌注在膀胱癌术后治疗中的效果观察

段晓波 赵鲁平 代庆德 李令勋 谭锐

河北医学Issue(1):92-94,3.
河北医学Issue(1):92-94,3.DOI:10.3969/j.issn.1006-6233.2014.01.033

呲柔比星膀胱内灌注在膀胱癌术后治疗中的效果观察

Observation of the Effects of Pirarubicin Through Intravesical Perfusion after the Surgery of Bladder Cancer

段晓波 1赵鲁平 1代庆德 1李令勋 1谭锐1

作者信息

  • 1. 四川省德阳市人民医院泌尿外科,四川 德阳 618000
  • 折叠

摘要

Abstract

Objective:To study the effect of pirarubicin ( THP) through intravesical perfusion after the surgery of bladder cancer and provide reference for clinical treatment .Method:85 transitional cell carcino-ma of bladder patients treated with surgery in our hospital were selected as research subjects.According to the patients accepted perfusion or not, They were divided into two groups.Patients in non-perfusion group were not underwent perfusion .Intravesical instillation of 30 mg of THP was given to patients in perfusion group once a week for 8 weeks, then subsequently once a month for 8 months.The patients were followed up and the treatment efficiency was evaluated .Result:1 year recurrence rate in perfusion group was 11 .3%, 2-year recurrence rate was 20.8%, 1-year recurrence rate in non-perfusion group was 46.9%, 2-year re-currence rate was 65.6%, the difference was statistically significant (P <0.05).After 10 months of treat-ment, the two groups of patients were adverse reactions of urinary frequency, urgency, dysuria and other symptoms of bladder irritation.There's statistically significant difference between the groups (P>0.05). Conclusion:Pirarubicin through intravesical perfusion after the surgery of bladder cancer can obviously re-duce postoperative recurrence rate.

关键词

呲柔比星/膀胱癌/膀胱内灌注

Key words

Pirarubicin/Bladder cancer/Intravesical perfusion

引用本文复制引用

段晓波,赵鲁平,代庆德,李令勋,谭锐..呲柔比星膀胱内灌注在膀胱癌术后治疗中的效果观察[J].河北医学,2014,(1):92-94,3.

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文